NCMHCE - National Clinical Mental Health Counseling Examination Psychopharmacology and Co-occurring Disorders 3

Question 1

A client prescribed clozapine for treatment-resistant schizophrenia asks their counselor why they need regular blood tests. What is the MOST accurate explanation?

Accepted Answer

To monitor for agranulocytosis, a potentially fatal decrease in white blood cells

Answer

Clozapine carries a unique risk of agranulocytosis, requiring mandatory regular CBC monitoring through the Clozapine REMS program.

Question 2

A client taking a monoamine oxidase inhibitor (MAOI) asks about dietary restrictions. Which food interaction is MOST dangerous?

Accepted Answer

Aged cheese causing hypertensive crisis

Answer

Tyramine in aged cheese interacts with MAOIs to cause potentially fatal hypertensive crisis, which is why strict dietary restrictions are required.

Question 3

When a client with co-occurring depression and chronic pain is prescribed duloxetine (Cymbalta), the counselor should understand that this medication was selected because it addresses which dual mechanism?

Accepted Answer

Serotonin and norepinephrine for both depression and pain modulation

Answer

Duloxetine is an SNRI that increases both serotonin and norepinephrine, which are involved in both mood regulation and descending pain inhibition pathways.

Question 4

A client taking an antipsychotic medication develops involuntary, repetitive facial movements and tongue protrusions that persist even when the medication is reduced. This MOST likely represents which condition?

Accepted Answer

Tardive dyskinesia

Answer

Tardive dyskinesia involves involuntary, repetitive movements of the face, tongue, and extremities that develop with long-term antipsychotic use and may be irreversible.

Question 5

A client with co-occurring opioid use disorder and Major Depressive Disorder is being treated with buprenorphine/naloxone (Suboxone) and an SSRI. The counselor should understand that buprenorphine works by which mechanism?

Accepted Answer

Partially activating opioid receptors, reducing cravings while preventing euphoria from additional opioid use

Answer

Buprenorphine is a partial opioid agonist that activates receptors enough to reduce cravings and withdrawal but has a ceiling effect that prevents euphoria.

NCMHCE - National Clinical Mental Health Counseling Examination Practice Test

NCMHCE - National Clinical Mental Health Counseling Examination Practice Test

NCMHCE - National Clinical Mental Health Counseling Examination Psychopharmacology and Co-occurring Disorders 3